and death. We graphically summarised length of stay distributions for each admission. Two sets of multistate models were fitted for each region using R's msm package: one with 3 states (alive in hospital, alive in the community, dead) and one with 8 states (allowing for up to 4 admissions). These models handle the competing risk of death and multiple events per person. We estimated total time spent in hospital and alive in the community by age and sex. Results: There were 234,720 patients in England and 37,185 in Lombardy admitted for HF. Despite close similarities in age, sex and common comorbidities of the two sets of patients, HF admissions in Lombardy were longer and more frequent per patient than in England, but short-and medium-term mortality was much lower. English patients had more very short stays, but their very elderly also had longer stays than their Lombardy counterparts. Using a three-state model, the predicted total time spent in hospital showed large differences between the countries: e.g. women in England spent an average of 24 days if aged 65 at first admission and 19 days if aged 85; in Lombardy these figures were 68 and 27 days respectively. However, these averages hide important variations: patients aged 85 had both shorter stays and longer stays in England than in Lombardy, as seen in their low lower quartile and high upper quartile and 90th percentiles. Eight-state models suggested disease progression that appeared similar in each country; inhospital death rates did not appear to vary by admission number. Conclusion: The healthcare systems of England and the northern Italian region of Lombardy share important similarities yet have very different admission patterns, length of stay and mortality for patients with HF. Higher bed occupancy and problems discharging elderly patients in England are among the likely explanations for these. Future modelling will include admissions for other causes in these patients. Objectives: Since 2007, Imperial College mortality alert surveillance system has generated monthly mortality alerts based on statistical process control charts for 122 individual diagnosis and surgical procedure groups using routinely collected hospital administrative data for all English acute NHS hospital trusts. The value of hospital mortality in relation to quality of care has been questioned but concerns tend to focus on summary measures. The strength of the Imperial system is the use of time series surveillance methods in specific diagnosis and procedure groups to detect sustained higher than expected death rates, above the random variation. We aimed to assess whether these mortality alerts were associated with external measures of hospital quality. Methods: We investigated the association of mortality alerts (for all conditions, acute myocardial infarction (AMI) and septicaemia) occurring with measures of quality relating to trust structure, processes and outcomes using regression techniques. Trust structure measures were provision of acute beds (acute bed occupancy); staffing levels (nurse to bed ratios); funding (trust financial data), staff training (GMC National training survey) and litigation risk assessment (Litigation authority risk assessment data). Our trust process measure was 'PCI within 90 minutes of arrival at heart centre'. Patient outcome measures were patient satisfaction (National Inpatient Survey data); harm (Patient Safety Thermometer); and summary measures of hospital mortality (SHMI and HSMR). We controlled for false discovery rate (a practical approach when multiple testing).
Objectives: Since 2007, Imperial College mortality alert surveillance system has generated monthly mortality alerts based on statistical process control charts for 122 individual diagnosis and surgical procedure groups using routinely collected hospital administrative data for all English acute NHS hospital trusts. The value of hospital mortality in relation to quality of care has been questioned but concerns tend to focus on summary measures. The strength of the Imperial system is the use of time series surveillance methods in specific diagnosis and procedure groups to detect sustained higher than expected death rates, above the random variation. We aimed to assess whether these mortality alerts were associated with external measures of hospital quality. Methods: We investigated the association of mortality alerts (for all conditions, acute myocardial infarction (AMI) and septicaemia) occurring with measures of quality relating to trust structure, processes and outcomes using regression techniques. Trust structure measures were provision of acute beds (acute bed occupancy); staffing levels (nurse to bed ratios); funding (trust financial data), staff training (GMC National training survey) and litigation risk assessment (Litigation authority risk assessment data). Our trust process measure was 'PCI within 90 minutes of arrival at heart centre'. Patient outcome measures were patient satisfaction (National Inpatient Survey data); harm (Patient Safety Thermometer); and summary measures of hospital mortality (SHMI and HSMR). We controlled for false discovery rate (a practical approach when multiple testing). Results: Ninety three NHS trusts were notified of 197 alerts triggered over the study period; 8 alerts for were for acute myocardial infarction; 19 for septicaemia. Trust acute bed occupancy was on average 2.2 (95% confidence interval: 0.9 to 3.6) percentage points higher in trusts which had a mortality alert compared with non-alerting trusts. Nurse bed ratio was −0.28 (−0.42 to −0.14) lower in alerting compared with non-alerting trusts. The proportion of alerting trusts in financial deficit was higher compared with non-alerting trusts risk ratio 1.72 (1.02 to 2.76). GMC National training satisfaction scores were lower in trusts that alerted for AMI. Mortality alerts were not associated with risk assessment ratings and there was insufficient evidence to detect an association between mortality alerts and our MINAP process measure. Mortality alerts were associated with patient satisfaction which was on average −1.32 (−2.14 to −0.51) percentage points lower in alerting compared with non-alerting trusts. Mortality alerts were also associated with summary measures of hospital mortality but were not associated with patient harms. Conclusion: Mortality alerts appear to reflect aspects of quality suggesting that there is value in a mortality alerting system in highlighting poor quality of care. Objectives: Transition of the patient from one physician to another throughout the therapeutic process; particularly in the transition from hospital to community, is a known weak point in the provision of safe, high quality care. The phenomenon is more prominent in patients with chronic illnesses, in light of the fact that these patients are usually receiving numerous medications and that their care is more fragmented. These patients therefore require closer supervision in disease management. Efforts are being made in Israel by the Health Funds to improve the maintenance of continuous treatment. The goals of this study were to evaluate the level of care continuity in chronic disease patients from four Health Funds, hospitalized at one medical center. Second, we have set out to learn about the association between maintaining continuity and clinical outcomes.
Methods: Enlistment of patients with chronic obstructive pulmonary diseases (COPD) or congestive heart failure (CHF), who had been hospitalized in the Department of Internal Medicine at Sheba Medical Center, due to worsening of their disease. During hospitalization, information was collected regarding patient admission, co-morbidities and socio-economic factors. Subsequently, information was collected regarding patient discharge. Telephone interviews were conducted with patients three months after discharge, to gather details about maintenance of discharge recommendations. Finally, patient charts (in the community) were reviewed by the research team, with the goal of confirming file updating and references to discharge recommendations. Results: 632 patients were enlisted; 220 with COPD and 401 with CHF; average age was 11.3 ± 74.9. Of this group, 28.1% had a readmission within one month; 5.4% deceased within one month; 12% deceased within three months.
The information gathered from all patient files led to the formulation of an index that reflects the extent of continuity maintenance (maximal score 6). The average score amongst participants in this study was 1.7 ± 3.5. No significant difference was found in this score between the various Health Funds. Logistic regression found the index to be an explicit factor protecting against mortality within one month (OR = 0.61; CI = 0.50-0.75); mortality within three months (OR = 0.73; CI = 0.63-0.84(; and readmissions within one month (OR = 0.81; CI = 0.73-0.90). Conclusion: This study found that maintenance of continuity of care in Israel requires improvement. Attempts made by the Health Funds to improve processes, did not show differences between the various funds. We have found a clear association between the level of continuity of care and patient outcomes. We thus assume that improvement in continuity of care will lead to improvement in outcomes, such as repeat hospitalizations and mortality.
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Objectives: The aim of the National Quality Profile is to present and analyse information on the quality of care in a format that allows for the evaluation and promotion of improvements in quality of care. The Health Service Executive (HSE) provides all public health services in Ireland. It publishes a large volume of data on a monthly basis, but challenges remain with using this information. The practice of comparing a current value to a target or a previous value fails to filter out noise (random variation within a normal range), which can lead to an overreaction to the perceived change. Furthermore, this practice fails to highlight signals of change which can lead to failure to react promptly. Methods: A screening tool based on the Irish definition of quality (HIQA 2012) was created and used to screen all HSE published indicators to determine their suitability for inclusion. Senior quality leaders ranked the indicators from the most to least important measure of quality of care. The highest ranking indicators were then analysed using Statistical Process Control (SPC) methods. Plan-DoStudy-Act (PDSA) cycles were used to identify the presentation style that best allowed senior leaders to evaluate the quality of care.
Methods included observation of senior management meetings, monthly surveys and interviews with senior leaders. Following ten PDSA cycles, the National Quality Profile was considered to be fit for purpose. Each indicator is presented in SPC charts showing the trend over time. Data are also presented in SPC funnel plots to show the variation across the HSE. Occurrences of special cause variation are annotated on the charts (Figure 1 ). The ISBAR (Identify, Situation, Background, Assessment, Recommendation) communication tool is used to explain the indicators, including occurrences of special and common cause variation.
There were no ethical considerations as data are anonymised and already published. Results: Presenting indicators in SPC charts shows evidence of improvements in quality of care that were missed by only comparing the current month to a previous value. The use of funnel plots to display the variation within the HSE shows occurrences of special cause variation, both better and worse than expected, that were also missed. Failure to detect improvements and special cause variation represents a missed opportunity to learn from successes and to identify areas where improvements are required. In addition, SPC charts show measures experiencing common cause variation being categorised as red, amber or green in a heat map which may be leading to overreaction. Conclusion: The key benefit of the National Quality Profile is the provision of timely, reliable and comprehensive information that describes quality of care in a way that demonstrates changes and can be used to promote improvements. Health care leaders are better informed about changes in quality of care by having access to this information. SPC charts can reliably distinguish potential signals from random variation. This permits appropriate reaction to significant signals when present, while also ensuring that normal variation is not interpreted as a signal requiring action.
The next steps are to further develop the National Quality Profile through engagement with key stakeholders; the automation of the creation of SPC charts to ensure the sustainability of the National Quality Profile; and the provision of data disaggregated to the most suitable level for the needs of different customers within the HSE. Reference 
